AxoGen, Inc. (AXGN) is a biotechnology company focused on the development and manufacture of innovative therapeutic products and therapies for peripheral nerve repair. Their products are designed to aid patients with peripheral nerve damage caused by traumatic injuries or surgical procedures. AxoGen specializes in utilizing advanced technologies and biological materials to support nerve cell regeneration and restore nervous system function. The company is a leading player in the field of regenerative medicine and is focused on providing innovative solutions for the treatment of patients with nerve injuries. Shares of AxoGen, Inc. (AXGN) may be attractive to investors seeking opportunities in the biotechnology and regenerative medicine sector.